Queensland Health's communicable diseases branch is testing the market for healthcare-associated infection surveillance systems with an eye on potentially purchasing a digital system compatible with contemporary mobile platforms.

The early market approach is not a formal commitment to acquiring a new system, the branch says, but it is interested in a potential solution that has the ability to conduct surveillance on bloodstream infections, significant organisms, surgical site surveillance, outbreaks and occupational exposures.